HomeUSAHeartX Accelerator Announces Five Startup Companies Selected for the 2023 Program

HeartX Accelerator Announces Five Startup Companies Selected for the 2023 Program


HeartX, powered by HealthTech Arkansas and MedAxiom along with eleven cardiology practices in Arkansas and around the country, has selected the five startup healthcare companies that will participate in the 2023 accelerator program.

HeartX is a cardiovascular-focused healthcare accelerator that facilitates guaranteed hospital pilot projects and clinical trials for accomplished, early-stage companies bringing new cardiovascular innovations to market.

The five companies selected for the 2023 HeartX program are:

Flosonics Medical, Canada

Flosonics Medical produces the FloPatch, a wireless, wearable Doppler ultrasound that directly assesses carotid arterial pulse within seconds. Data from the FloPatch provides a window to the left ventricle, which helps clinicians determine when a patient is no longer fluid-responsive, avoiding harmful and ineffective IV fluids.

Happitech, Netherlands

Happitech offers an accessible and scalable solution for identifying patients at risk of atrial fibrillation (AF). By placing a finger on a smartphone’s camera for 90 seconds, individuals can screen for AF with a sensitivity and specificity similar to the standard of care. This is suited for at-risk underserved populations, the elderly, and low-income individuals promoting improved health equity.

MindMics, Massachusetts, United States

MindMics delivers heart monitoring through low-frequency acoustical vibrations detected in the ear canal with technology embedded in earbuds and hearing aids. The results are highly accurate regardless of skin tone, skin thickness, and body mass. The sound-based technology has been clinically validated in collaboration with leading researchers and world-renowned medical institutions.

Nanowear, New York, United States

Nanowear is an AI-based remote diagnostics tool utilizing proprietary patented cloth-based nanotechnology. The nanosensors capture over 85 medical-grade biomarkers directly from the skin, enabling a closed-loop digital system for specific machine-learning algorithms built on terabytes of unique human data.

SmartCardia, Switzerland

SmartCardia produces the 7L Patch, a revolutionary platform and 7-Lead ECG patch for cardiology and remote patient monitoring (RPM) that is a breakthrough 7/14 day patch offering real-time 7-Lead ECG and vitals with SaaS. A single patch serves multiple service types: Mobile Cardiac Telemetry, RPM, Holter, Extended Holter, and Event Monitoring.

Each company will receive $150K of investment capital as well as complete and total access to clinicians and administrators while executing their pilot projects and clinical studies in the HeartX program.

Led by Jeff Stinson, director, HealthTech Arkansas operates HeartX, a flagship accelerator that recruits worldwide for the most accomplished cardiovascular-focused startups in the areas of digital health, medical devices, and diagnostic platforms.

MedAxiom, an American College of Cardiology Company, aims to transform cardiovascular care by combining the knowledge of hundreds of cardiovascular organization members, thousands of administrators, clinicians and revenue cycle experts, and dozens of industry partners.